Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma
Autoimmune haemolytic anaemia (AIHA) in mantle cell lymphoma (MCL) is a rare but life-threatening complication. To date, there are no relevant data for treatment of AIHA in MCL. Ibrutinib, which has been approved for relapse/refractory MCL, is an immunomodulatory drug inhibiting Th2 activation and c...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
Karger Publishers
2017-01-01
|
| 丛编: | Case Reports in Oncology |
| 主题: | |
| 在线阅读: | http://www.karger.com/Article/FullText/456002 |
| 标签: |
没有标签, 成为第一个标记此记录!
|